Shenzhen Neptunus Bioengineering Co., Ltd.
|
32.3 Billion CNY
|
90.802%
|
Anhui Fengyuan Pharmaceutical Co., Ltd.
|
4.39 Billion CNY
|
32.338%
|
Dong-E-E-Jiao Co.,Ltd.
|
13.3 Billion CNY
|
77.67%
|
Livzon Pharmaceutical Group Inc.
|
25.04 Billion CNY
|
88.136%
|
Hainan Haiyao Co., Ltd.
|
7.36 Billion CNY
|
59.666%
|
Tus-Pharmaceutical Group Co., Ltd.
|
1.15 Billion CNY
|
-158.118%
|
Jilin Aodong Pharmaceutical Group Co., Ltd.
|
32.26 Billion CNY
|
90.791%
|
Changchun High-Tech Industries (Group) Inc.
|
30.74 Billion CNY
|
90.335%
|
Apeloa Pharmaceutical Co.,Ltd
|
12.76 Billion CNY
|
76.728%
|
PKU HealthCare Corp.,Ltd.
|
2.43 Billion CNY
|
-21.858%
|
Chengdu Huasun Technology Group Inc., Ltd.
|
2.13 Billion CNY
|
-39.268%
|
Dezhan Healthcare Company Limited
|
5.37 Billion CNY
|
44.758%
|
Jinling Pharmaceutical Company Limited
|
4.55 Billion CNY
|
34.705%
|
Jiuzhitang Co., Ltd.
|
5.32 Billion CNY
|
44.252%
|
Huapont Life Sciences Co., Ltd.
|
30.72 Billion CNY
|
90.33%
|
Zhejiang Jingxin Pharmaceutical Co., Ltd.
|
7.98 Billion CNY
|
62.797%
|
Shandong Wohua Pharmaceutical Co., Ltd.
|
1.14 Billion CNY
|
-159.564%
|
Hengkang Medical Group Co., Ltd.
|
6.08 Billion CNY
|
51.132%
|
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
|
6.45 Billion CNY
|
53.995%
|
Qianjiang Yongan Pharmaceutical Co., Ltd.
|
2.34 Billion CNY
|
-26.59%
|
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
|
19.2 Billion CNY
|
84.527%
|
Jinhe Biotechnology CO., LTD.
|
5.45 Billion CNY
|
45.52%
|
Teyi Pharmaceutical Group Co.,Ltd
|
2.51 Billion CNY
|
-18.252%
|
Kunming Longjin Pharmaceutical Co., Ltd.
|
631.63 Million CNY
|
-370.407%
|
Beijing Aosaikang Pharmaceutical Co., Ltd.
|
3.52 Billion CNY
|
15.682%
|
Chengdu Kanghong Pharmaceutical Group Co., Ltd
|
8.52 Billion CNY
|
65.166%
|
Anhui Huangshan Capsule Co., Ltd.
|
1.1 Billion CNY
|
-169.358%
|
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd
|
2.12 Billion CNY
|
-39.822%
|
Zhuhai Rundu Pharmaceutical Co., Ltd.
|
2.22 Billion CNY
|
-33.373%
|
Huaren Pharmaceutical Co., Ltd.
|
5.16 Billion CNY
|
42.481%
|
Tianjin Ringpu Bio-Technology Co.,Ltd.
|
6.59 Billion CNY
|
54.953%
|
Shanxi Zhendong Pharmaceutical Co.,Ltd
|
6.18 Billion CNY
|
51.925%
|
Fuan Pharmaceutical (Group) Co., Ltd.
|
5.97 Billion CNY
|
50.28%
|
Hybio Pharmaceutical Co., Ltd.
|
3.27 Billion CNY
|
9.336%
|
Baotou Dongbao Bio-Tech Co.,Ltd
|
2.74 Billion CNY
|
-8.36%
|
Hunan Er-Kang Pharmaceutical Co., Ltd
|
5.47 Billion CNY
|
45.771%
|
Changjiang Pharmaceutical Group Co., Ltd.
|
3.44 Billion CNY
|
13.771%
|
Zhejiang Garden Bio-chemical High-tech Co., Ltd.
|
5.26 Billion CNY
|
43.519%
|
Fujian Cosunter Pharmaceutical Co., Ltd.
|
1.61 Billion CNY
|
-84.037%
|
Beijing Science Sun Pharmaceutical Co., Ltd.
|
3.62 Billion CNY
|
17.971%
|
Zhejiang Xinguang Pharmaceutical Co., Ltd.
|
930.4 Million CNY
|
-219.35%
|
Hainan Poly Pharm. Co., Ltd
|
6.28 Billion CNY
|
52.738%
|
Jiangxi Synergy Pharmaceutical Co., Ltd.
|
3.22 Billion CNY
|
7.766%
|
Shandong Xinhua Pharmaceutical Company Limited
|
8.35 Billion CNY
|
64.435%
|
Zhejiang Tianyu Pharmaceutical Co., Ltd.
|
6.33 Billion CNY
|
53.121%
|
PharmaBlock Sciences (Nanjing), Inc.
|
5.1 Billion CNY
|
41.786%
|
Jinghua Pharmaceutical Group Co., Ltd.
|
3.18 Billion CNY
|
6.711%
|
Zhejiang Hisoar Pharmaceutical Co., Ltd.
|
7.52 Billion CNY
|
60.489%
|
Betta Pharmaceuticals Co., Ltd.
|
9.14 Billion CNY
|
67.516%
|
Tibet AIM Pharm. Inc.
|
927.74 Million CNY
|
-220.266%
|
Shenzhen Kangtai Biological Products Co., Ltd.
|
15.08 Billion CNY
|
80.304%
|
Shandong Shanda Wit Science and Technology Co., Ltd.
|
5.19 Billion CNY
|
42.842%
|
Pacific Shuanglin Bio-pharmacy Co., LTD
|
8.63 Billion CNY
|
65.573%
|
Zhejiang AngLiKang Pharmaceutical CO.,LTD.
|
3.01 Billion CNY
|
1.614%
|
Xiamen Kingdomway Group Company
|
5.35 Billion CNY
|
44.498%
|
ShanXi C&Y Pharmaceutical Group Co., Ltd.
|
1.43 Billion CNY
|
-107.334%
|
Walvax Biotechnology Co., Ltd.
|
15.58 Billion CNY
|
80.94%
|
Sunflower Pharmaceutical Group Co.,Ltd
|
6.88 Billion CNY
|
56.825%
|
Harbin Gloria Pharmaceuticals Co., Ltd
|
3.15 Billion CNY
|
5.748%
|
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
|
40.14 Billion CNY
|
92.599%
|
Hunan Hansen Pharmaceutical Co., Ltd.
|
2.33 Billion CNY
|
-27.167%
|
Changzhou Qianhong Biopharma CO.,LTD
|
2.76 Billion CNY
|
-7.417%
|
Shenzhen Weiguang Biological Products Co., Ltd.
|
2.87 Billion CNY
|
-3.284%
|
Honz Pharmaceutical Co., Ltd.
|
2.16 Billion CNY
|
-37.201%
|
Northeast Pharmaceutical Group Co., Ltd.
|
15.27 Billion CNY
|
80.547%
|
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd
|
4.52 Billion CNY
|
34.269%
|
Guizhou Xinbang Pharmaceutical Co., Ltd.
|
9.24 Billion CNY
|
67.861%
|
Tianjin Lisheng Pharmaceutical Co.,Ltd.
|
5.78 Billion CNY
|
48.6%
|
Zhejiang Yatai Pharmaceutical Co., Ltd.
|
1.42 Billion CNY
|
-107.871%
|
Zhejiang NHU Company Ltd.
|
39.15 Billion CNY
|
92.412%
|
ApicHope Pharmaceutical Co., Ltd
|
4.4 Billion CNY
|
32.553%
|
Shanghai Kaibao Pharmaceutical CO.,Ltd
|
4.57 Billion CNY
|
35.121%
|
Beijing SL Pharmaceutical Co., Ltd.
|
6.27 Billion CNY
|
52.67%
|
Yunnan Baiyao Group Co.,Ltd
|
53.78 Billion CNY
|
94.476%
|
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD
|
1.33 Billion CNY
|
-122.291%
|
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.
|
1.54 Billion CNY
|
-92.599%
|
Guangdong Lifestrong Pharmacy Co., Ltd.
|
855.53 Million CNY
|
-247.297%
|
Huadong Medicine Co., Ltd
|
33.5 Billion CNY
|
91.133%
|
Jiangsu Nhwa Pharmaceutical Co., LTD
|
7.32 Billion CNY
|
59.455%
|
Harbin Medisan Pharmaceutical Co., Ltd.
|
3.44 Billion CNY
|
13.701%
|
LanZhou Foci Pharmaceutical Co.,Ltd.
|
2.52 Billion CNY
|
-17.529%
|
Tianjin Chase Sun Pharmaceutical Co.,Ltd
|
11.83 Billion CNY
|
74.894%
|
Beijing Beilu Pharmaceutical Co., Ltd
|
2.81 Billion CNY
|
-5.385%
|
Nanjing Hicin Pharmaceutical Co., Ltd.
|
1.41 Billion CNY
|
-109.406%
|
Renhe Pharmacy Co., Ltd.
|
7.44 Billion CNY
|
60.089%
|
Chongqing Pharscin Pharmaceutical Co., Ltd.
|
1.85 Billion CNY
|
-60.482%
|
Zhejiang Xianju Pharmaceutical Co.,Ltd.
|
6.99 Billion CNY
|
57.51%
|
Luoxin Pharmaceuticals Group Stock Co., Ltd.
|
5.11 Billion CNY
|
41.938%
|
Guizhou Bailing Group Pharmaceutical Co., Ltd.
|
7.34 Billion CNY
|
59.57%
|